PARKER___Immunotherapy_an-4b5f9f10a8fe2fb907475fd2fa8a2c34c701669b

A combination of immunotherapy and chemotherapy shrank tumors in advanced pancreatic cancer patients, according to early study results being presented March 31. The trial was conducted by the Parker Institute for Cancer Immunotherapy and its partners.

Leave a Reply